[Webinar / ASGE] Risk Stratification and Management of Dysplastic Barrett’s Esophagus

Beyond 2020 Vision: Current Management of Barrett's Esophagus (BE)* Risk stratification is important in managing BE patients and biomarker assays such as TissueCypher® are “ready for Prime Time” in identifying patients at high risk for progression. Presented by Marcia Canto, MD MHS (Johns Hopkins University Division of Gastroenterology) and the American Society for Gastrointestinal Endoscopy (ASGE) All content is derived from presentations and similar offerings made at Digestive Disease Week® 2021 and is presented with permission of DDW, LLC.